Ledger.Open graph →
SEC Form D · Amendment · filed November 13, 2018

RELMADA THERAPEUTICS, INC

Offering
$10.0M
Sold
$4.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ottavio Vitolo · New York, NYExecSergio Traversa · New York, NYExec · DirectorPaul Kelly · New York, NYDirectorMaged Shenouda · New York, NYDirectorJohn King · East Brunswick, NJExec · DirectorJoseph Esteves · East Brunswick, NJDirectorKieran Snyder · Seattle, WAExecInvestments Minetta · Brooklyn, NYDirectorRichard R. Gray · Coppell, TXExec · DirectorDenmar R. Dixon · Coppell, TXDirectorJoseph R. Reece · Coppell, TXDirectorKaren A. Nista · West Hartford, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗